📈 New phase 3 trial in #lungcancer Retifanlimab vs placebo with platinum-based chemotherapy in patients with first-line metastatic non-small-cell lung cancer (POD1UM-304) Retifanlimab improved overall survival compared with placebo when added to platinum-based chemotherapy tinyurl.com/483jf7k8

📚 New Editorial Farming life: a double-edged sword for respiratory health The #farming environment is an exemplar of disparate and antagonistic influences on respiratory health www.thelancet.com/journals/lan...

💡Spotlight Chrysotile asbestos—the deadly consequences of a retreat from national bans "There is no safe level of asbestos, whether chrysotile or amphibole, and global bans remain the only solution to this ongoing devastating occupational health tragedy" tinyurl.com/5n7rctz2

📰The Lancet Respiratory Medicine’s September issue is out now Read content on obstructive sleep apnoea, #tuberculosis, cardiogenic shock, #pneumonia, and much more Check out the full issue here: bit.ly/3P2PVls

🗞️ News Vaccine disinformation motivated gunman's attack on US CDC headquarters @bryantfurlow.bsky.social tinyurl.com/mu2nen8d

Abrupt funding cuts to international aid are disrupting essential tuberculosis (TB) services. Ending TB remains within reach—but only with adequate adaptation, investment, and will. New Comment ⤵️ tinyurl.com/2xccptr5

🌎 Symposium Spotlight Join us at the Union World conference on Lung Health for a critical symposium with The Lancet Global Health Commission on Medical Oxygen Security. 🗓️18 November 2025 ⏰ 11:30 - 13:00

📰 The US FDA has approved the first immunotherapy for recurrent respiratory papillomatosis tinyurl.com/3db69ye4 Approval is based on a pivotal phase 1/2 clinical trial of PRGN-2012 gene therapy published in @lancetrespirmed.bsky.social 🔗 Check out the full trial results here: tinyurl.com/yzjdc665

💡New Spotlight Unique perspective on cystic fibrosis at @edfringe.bsky.social by Peter Ranscombe tinyurl.com/5r8sykbn

📄✨ New publication! A @lancetrespirmed.bsky.social study co-authored by #AusHSI Prof Stephanie Yerkovich and Prof Anne Chang highlights geographical variations in childhood bronchiectasis and its management using data from the international Child-BEAR-Net Registry. 🔗 Read the paper: bit.ly/46RdLdx

The Trump administration’s sweeping deregulation, funding cuts, and layoffs are undermining workplace respiratory health protection and research, say experts. Explore what it means for workers in @lancetrespirmed.bsky.social ⤵️ bit.ly/3J7jW3d

🗞️ News from the US covered by @bryantfurlow.bsky.social Trump administration decimates worker health oversight tinyurl.com/3kpx4fdf US FDA authorises Juul e-cigarette marketing, imperilling youth #vaping declines tinyurl.com/23hn996v

New Comment - Pre-#COPD: an evolving concept with practice potential The concept of pre-COPD holds strong potential for both clinical and public health strategies 🔗 tinyurl.com/4a6wtcds

🎙️For new followers, our Podcast is a monthly audio companion to the journal, covering all things respiratory and critical care, from #longCOVID to #tobacco control, #asthma, #TB, #sepsis, and more 🎧Listen to previous episodes here: www.buzzsprout.com/admin/145996... #lungsky #MedSky

So honoured and humbled to be profiled by @lancetrespirmed.bsky.social

📑 New Article available #OpenAccess Type 2 inflammation biomarkers and their association with response to dupilumab in #COPD (BOREAS): an analysis of a randomised, placebo-controlled, phase 3 trial tinyurl.com/b34yzm3v #lungsky #respmed

📚 August issue of The Lancet Respiratory Medicine out now! Read the full issue here: lnkd.in/eh_i8K2k This issue includes groundbreaking research on #NSCLC, #COPD, and #bronchiectasis, alongside important discussion on a variety of #respiratory and #criticalcare topics

🎙️Check out our latest podcast, accompanying our Series on the Global Epidemiology of Chronic Respiratory Disease 🫁 Diana Stanley is joined by Joan Soriano to discuss the Series, exploring diagnostic challenges, global trends, and future directions for prevention 🎧Listen here: tinyurl.com/2p5a8273

The Union World Conference on Lung Health is a vital source of the latest breakthroughs in tuberculosis and lung disease. 📰 Even now, studies presented last year in Bali, Indonesia are being published, like the endTB-Q trial in @lancetrespirmed.bsky.social: www.thelancet.com/journals/lan...

🚨New phase 4 trial: Effect of riociguat on exercise after balloon pulmonary angioplasty in inoperable #CTEPH (THERAPY-HYBRID-BPA) Findings suggested that continuation of riociguat post-BPA might attenuate the worsening of exercise intolerance without increasing adverse events tinyurl.com/y7yh8bkp

Chronic respiratory diseases constitute one of the most pressing, yet underappreciated, global health burdens. A new @lancetrespirmed.bsky.social Series explores the epidemiology of asthma, COPD, & ILD & discusses policy solutions to improve diagnosis & access to care: tinyurl.com/mpuv4jsj

🖼️ Infographic: Facing the looming rise in global #asthma cases tinyurl.com/5bhca654 The number of individuals with asthma worldwide is expected to grow, particularly in deprived areas Explore our infographic, and read the full paper here: tinyurl.com/2s45kbff

🎙️NUOVO Podcast (in Italian) Lorenzo Guglielmetti parla dello studio clinico endTB-Q per valutare l’efficacia e la sicurezza di un regime di farmaci per curare la #tubercolosi in individui con pre-XDR tubercolosi. 🎧Ascoltatelo 👉 tinyurl.com/4bfkzhud 🔗E leggete l'articolo 👉 tinyurl.com/4y4kf35y

🚨New Series: Global Epidemiology of Chronic Respiratory Disease This Series focuses on the global epidemiology of #asthma, #COPD, and #ILD, and a Policy Review on #tobacco, the main, avoidable risk factor of lung disease, completes the Series. 🔗 www.thelancet.com/series-do/gl...

🎙️NEW Podcast We were pleased to be joined by Dr Mitnick & Dr Guglielmetti to discuss the endTB-Q trial to evaluate the efficacy and safety of a drug regiment to treat #TB in individuals with pre-XDR tuberculosis. 🎧Listen here: tinyurl.com/mw2u2u8z 🔗Read the full article: tinyurl.com/4y4kf35y

📚 New Viewpoint #OpenAccess 📑Eosinophils in #asthma phenotypes: perpetrators or guilty by association? "Data suggest that eosinophilia should not be considered a #TreatableTrait in people with chronic airway diseases, but only a complement to an accurate clinical diagnosis" 🔗 tinyurl.com/2bve3dne

▶️ Evaluation of the effect of multimorbidity on difficult-to-treat #asthma using a novel score (MiDAS): a multinational study of asthma cohorts Findings indicate that an airway-centric approach is inadequate and that multidisciplinary care is imperative 🔗 Read more here: tinyurl.com/yrbn7h4x

New Research: Efficacy, immunogenicity, and safety of a next-generation mRNA-1283 COVID-19 vaccine compared with the mRNA-1273 vaccine (NextCOVE): results from a phase 3, randomised, observer-blind, active-controlled trial www.thelancet.com/journals/lan...

New @thelancetoncol.bsky.social - Patterns in genomic mutations among patients with early-onset colorectal cancer: an international, multicohort, observational study www.thelancet.com/journals/lan... #GastroSky #OncSky #MedSky

There is an urgent need to expand access to life-saving transplants. Today at 6pm BST, join a webinar where experts will discuss past, present, & future advances in organ transplantation. Register ➡️ hubs.li/Q03vNF380 @ttsorg.bsky.social @astinfo.bsky.social

Are you ready for your research to spark global conversation? ✨ Begin your publication journey with us today and help to advance health and science worldwide. hubs.li/Q03vpxN70

We are the world-leading respiratory medicine and critical care journal. While a partial measurement of our impact, we are pleased to share our Impact Factor of 32·8 and CiteScore of 53·2. hubs.li/Q03vf3y10

🎙️New Podcast We were pleased to be joined by Dr Garriga-Grimau to discuss the first multi-country cohort study to describe the clinical features and standards of care for children and young people with #bronchiectasis. 🎧Listen here: shorturl.at/N301H 🔗Linked paper: shorturl.at/faVsy

In the UK, the House of Commons has approved the Terminally Ill Adults Bill amid narrowing support and ongoing debate. ✍️ Jacqui Thornton reports: tinyurl.com/467su243

⏰ New #OpenAccess Article 📚 Adjuvant #chemotherapy for stage IA–IIA non-squamous, non-small-cell #lungcancer identified as molecular high-risk by a 14-gene expression profile (AIM-HIGH): a phase 3 trial 🔗 Read in full here: tinyurl.com/2azvwunp #NSCLC

New research article Centrifuge-free stool processing methods for Xpert MTB/RIF Ultra #tuberculosis diagnosis in children in Uganda and Zambia: an observational, prospective, diagnostic accuracy study www.thelancet.com/journals/lan... #IDSky #ClinMIcro #MicroSky #TBSky #TB #OpenAccess #OA

Ahead of our July issue, our latest editorial is available online Overcoming the dilemma of #dengue diagnostics www.thelancet.com/journals/lan... #IDSky #ClinMicro #ViroSky #OpenAccess #OA

📢NEW: June issue now online featuring #asthma, #stroke, #sarcoma, #ulcerativecolitis, #TB, #anxiety, #schizophrenia, #PCOS and much more with our editorial on the rising burden of pollen allergy All available #OpenAccess Read more here: www.thelancet.com/issue/S2589-... Attribution: Getty #MedSky

📰 News 2025 #GINA report for #asthma by Priya Venkatesan Read our summary of the main updates to this years Global Strategy for Asthma Management and Prevention guidance report tinyurl.com/2duynp6e

🧬 Explore our July 2025 issue now! We cover a wide variety of important subjects including influenza, sepsis, lifecourse trajectories, ARDS and much more! 🔗 bit.ly/3P2PVls

🆕 In our first Online First Article, Zhaonan Wang and colleagues "provide a UK-based perspective on the increasing burden of ARLD and sociodemographic variation in both burden and outcomes.” Read more ➡️ www.thelancet.com/journals/lan...

Less invasive test could replace endoscopies for over half of patients monitored for oesophageal cancer risk, study suggests. Explore the research 👉 tinyurl.com/4xxxcne4

The State of the Air report from the ALA reports worsening ozone pollution 📑 tinyurl.com/mt526f4k Extreme heat and wildfires are highlighted, both featured in our recent Editorials: 📗 Health effects from climate-driven events tinyurl.com/y9sde7y2 📘 Extreme heat tinyurl.com/83myyv2h

🗞️ News Medical societies unite against RFK Jr's COVID vaccine update by Tony Kirby 🔗https://tinyurl.com/5bhej6ex

📰 News: #ATS2025 Conference round up 2025 American Thoracic Society International Conference by Priya Venkatesan tinyurl.com/978c8jnb @atscommunity.bsky.social

📜 Editorial: Housing is Health Care #Homelessness introduces risk for many respiratory diseases "Although homelessness is a huge problem, the respiratory community must remember that small steps to reduce stigma and improve health access are the start of bigger change" 🔗 tinyurl.com/4bmcpmpt

📜 Review: Extracorporeal cardiopulmonary resuscitation for refractory cardiac arrest Ongoing research aims to assess the efficacy of ECPR versus continued CCPR and uncover key prognostic indicators. 🔗 Available Open Access here: tinyurl.com/2nbv23pb

🎙️ New Podcast We were pleased to be joined by Prof Marcus Schultz and Dr Prashant Nasa to discuss their Position Paper reporting insights from an international Delphi expert panel on defining and subphenotyping #ARDS. 🎧 Listen here: lnkd.in/eaApUxp2 📰 Read the full paper here: lnkd.in/ecKuUPVR

Tuberculosis continues to pose a serious threat to public health in Sudan. "The long-term risks of an uncontrolled tuberculosis epidemic...are far reaching and demand immediate global health attention", say authors of a new letter. Read now 👉 tinyurl.com/2ns7uk93

Happy to share our recent review article on Extracorporeal Cardiopulmonary Resuscitation in refractory cardiac arrest published in @lancetrespirmed.bsky.social covering all aspects and recent evidence of #ECPR for in-hospital and out-of-hospital cardiac arrest #OHCA #IHCA Open Access bit.ly/3HjVSsV